BAF complex inhibitors in neuronal development and functions
BAF complex inhibitors in neuronal development and functions
批准号:
10528055
负责人:
Emily Carla Dykhuizen
金额:
$20.41万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-06-01 至 2024-05-31
关键词:
ACTL6B geneARID1A geneAttenuatedAutomobile DrivingBrainCaliforniaCellsChIP-seqChemicalsChildChromatinChromatin Remodeling FactorCombinatoricsComplexDNA Polymerase IIDNA biosynthesisDNA-Directed RNA PolymeraseDataDevelopmentDiseaseEarly Gene TranscriptionsElectrophysiology (science)Epigenetic ProcessEtiologyEyeFibrinogenFunding OpportunitiesFutureGenesGeneticGenetic TranscriptionHumanImmediate-Early GenesIn VitroIntellectual functioning disabilityInterventionKnowledgeLaboratoriesLaboratory ChemicalsMediatingMicroelectrodesModificationMolecularMutateMutationNeurodevelopmental DisorderNeuronsNuclear Pore ComplexOutcomePharmacologyPhotoaffinity LabelsPropertyProteomicsRattusRegulationRegulator GenesRisk FactorsRoleSMARCA2 geneSMARCC2 geneStructureSucroseSynapsesTestingTranscriptional RegulationUnited States National Institutes of HealthUniversitiesUp-Regulationanalogattenuationautism spectrum disorderbasechromatin remodelingcytotoxicitydisorder riskefficacy testingfollow-upgenome-widegenome-wide analysishigh throughput screeninginduced pluripotent stem cellinhibitorinsightknock-downloss of function mutationneurodevelopmentneuron developmentnovelpreventpromoterrepairedresponsescaffoldsmall moleculesmall molecule inhibitorsynaptic functiontooltranscriptome sequencing
中文摘要
项目摘要
神经发育障碍(NDD)正在以惊人的速度在我们的儿童中变得越来越普遍。
最近的全基因组研究表明,NDD和功能缺失突变之间存在很强的相关性,
编码BAF(别名mSWI/SNF)染色质重塑复合物亚基的基因。尽管如此强大
相关证据表明,BAF复合物在神经发育基因转录中的确切作用仍然存在
部分原因是缺乏有效的化学/药理学工具来破坏BAF功能。在
对NIH资助机会的回应,题为“发现新大脑的细胞基化学探针”
该项目将进一步开发和测试一组有前途的BAF抑制剂,
并使用这些抑制剂来探测神经元中这些染色质重塑复合物的功能。
活动诱导的基因转录,神经元成熟的关键分子驱动力。本项目的具体目标
是:1)化学修饰“命中”分子BAFi以增加神经元细胞中的效力,以及2)确定
BAF复合物在神经发育重要活性诱导的基因转录中的作用。该项目将
在两个实验室同时进行,这两个实验室分别具有开发
染色质重塑的小分子抑制剂(普渡大学Dykhuizen实验室;目标1)和
活动诱导的神经元基因转录(加州大学萨哈实验室,默塞德;目的2)。
总之,这项研究将产生有价值的化学工具,研究BAF复杂的功能和更深层次的
深入了解驱动正常神经发育的表观遗传机制,这将填补知识空白
BAF突变与其结果之间的关系,如NDD。
英文摘要
PROJECT SUMMARY
Neurodevelopmental disorders (NDDs) are becoming more prevalent among our children at an alarming rate.
Recent genome-wide studies suggest a strong correlation between NDDs and loss-of-function mutations in
genes encoding subunits of the BAF (alias, mSWI/SNF) chromatin remodeling complex. Despite such strong
correlative evidence, the precise role(s) of the BAF complex in neurodevelopmental gene transcription remains
largely unexplored, in part, due to lack of efficient chemical/pharmacological tools to disrupt BAF function. In
response to the NIH funding opportunity titled, ‘Discovery of Cell-based Chemical Probes for Novel Brain
Targets’, this project will further develop and test a promising group of BAF inhibitors in maturing rat cortical
neurons and use these inhibitors to probe the function of these chromatin remodeling complexes in neuronal
activity-induced gene transcription, a key molecular driver of neuronal maturation. Specific aims of this project
are: 1) Chemically modify ‘hit’ molecule BAFi to increase potency in neuronal cells, and 2) Determine the role
of BAF complex in neurodevelopmentally important activity-induced gene transcription. The project will be
conducted simultaneously in two laboratories with long standing expertise in –respectively– development of
small molecule inhibitors of chromatin remodelers (the Dykhuizen laboratory at Purdue university; aim 1) and
activity-induced neuronal gene transcription (the Saha laboratory at University of California, Merced; aim 2).
Taken together, this study will generate valuable chemical tools to study BAF complex functions and deeper
insights into epigenetic mechanisms driving normal neurodevelopment, which will fill in the knowledge gap
between BAF mutations and their outcomes, such as NDDs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BAF complex inhibitors in neuronal development and functions
-
批准号:10630241
-
项目类别:
-
资助金额:$22.88万
-
财政年份:2022
-
负责人:Emily Carla Dykhuizen
-
依托单位:
Purdue Drug Discovery Training Program
-
批准号:10428481
-
项目类别:
-
资助金额:$20.81万
-
财政年份:2019
-
负责人:Emily Carla Dykhuizen
-
依托单位:
Purdue Drug Discovery Training Program
-
批准号:10620817
-
项目类别:
-
资助金额:$19.94万
-
财政年份:2019
-
负责人:Emily Carla Dykhuizen
-
依托单位:
The tumor suppressive role of PBRM1, the bromodomain-containing subunit of the PBAF chromatin remodeling complex
-
批准号:9908057
-
项目类别:
-
资助金额:$34.92万
-
财政年份:2017
-
负责人:Emily Carla Dykhuizen
-
依托单位:
The tumor suppressive role of PBRM1, the bromodomain-containing subunit of the PBAF chromatin remodeling complex
-
批准号:9311552
-
项目类别:
-
资助金额:$34.94万
-
财政年份:2017
-
负责人:Emily Carla Dykhuizen
-
依托单位: